Using phage display for rational engineering of a higher-affinity humanized 3’ phosphohistidine-specific antibody
Histidine phosphorylation is a non-canonical post-translational modification (PTM), with 1-phosphohistidine (1-pHis) and 3-phosphohistidine (3-pHis) isoforms, that is understudied due to a lack of robust reagents, including high-affinity pHis-specific antibodies. Engineering pHis antibodies is challenging due to the labile nature of its phosphoramidate (P-N) bond. We developed a strategy for in vitro engineering of antibodies for the detection of native 3-pHis targets, in which the rabbit SC44-8 anti-3-pTza mAb is humanized into a scaffold (hSC44) that is suitable for phage display. Six unique Fab phage-displayed hSC44 scaffold libraries were screened for antibodies that bound 3-pHis with higher affinity and had specificity for 3-pHis versus 3-pTza. hSC44.20N32F<sup>L</sup>, the best engineered antibody, has ~10-fold higher affinity for 3-pHis than parental hSC44. Eleven new Fab structures, including the first antibody-pHis peptide structures, together with structural and quantum mechanical calculations, provided molecular insights into 3-pHis and 3-pTza discrimination by hSC44.20N32F<sup>L</sup> and the increased affinity obtained through engineering. We demonstrated the utility of these high-affinity 3-pHis-specific antibodies for the recognition of pHis proteins in mammalian cells by immunoblotting and immunofluorescence staining. Our work describes a general method for engineering labile PTM-specific antibodies and provides novel antibodies for investigating the role of 3-pHis in cell biology.
Authors
- Ian A. Wilson (ORCID: https://orcid.org/0000-0002-6469-2419)
- Tony Hunter (ORCID: https://orcid.org/0000-0002-7691-6993)
- Gianluca Veggiani (ORCID: https://orcid.org/0000-0002-4064-0112)
- Jill Meisenhelder (ORCID: https://orcid.org/0000-0001-9026-7101)
- Margaux Sala (ORCID: https://orcid.org/0000-0003-3483-361X)
- Indrani Choudhuri (ORCID: https://orcid.org/0000-0002-5829-4625)
- Ronald M. Levy (ORCID: https://orcid.org/0000-0001-8696-5177)
- Sachdev S. Sidhu (ORCID: https://orcid.org/0000-0001-7755-5918)
- Avik Biswas (ORCID: https://orcid.org/0000-0002-3519-3944)
- Robyn L. Stanfield (ORCID: https://orcid.org/0000-0001-9521-9184)
- Rajasree Kalagiri (ORCID: https://orcid.org/0000-0002-4817-3563)
- Dmitry Lyumkis (ORCID: https://orcid.org/0000-0002-8124-7472)
- Gregory D. Martyn (ORCID: https://orcid.org/0000-0002-7373-7834)
- Chao Chen (ORCID: https://orcid.org/0000-0003-1065-211X)
Institutions
- Louisiana State University (US)
- Scripps Research Institute (US)
- Salk Institute for Biological Studies (US)
- University of Waterloo (CA)
- Regional Municipality of Waterloo (CA)
- University of California San Diego (US)
- Temple University (US)
Publication Details
- Journal
- Communications Chemistry
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1038/s42004-025-01768-9
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Energy
- National Institutes of Health
- Office of Science
- National Cancer Institute
- National Institute of General Medical Sciences
- Basic Energy Sciences
- Biological and Environmental Research
- Argonne National Laboratory
- SLAC National Accelerator Laboratory